Iranian Journal of Medical Sciences

Document Type: Review Article

Authors

1 Centre for Complementary Medicine Research, University of Western Syd-ney, Campbelltown Campus, Sydney, Australia; Faculty of Applied Science, University of Canberra, Canberra, Australia

2 Department of Neuroscience, School of Advanced Medical Technologies, Tehran University of Medical Science, Tehran, Iran; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Glycation is a protein modification, which results in a change in a protein structure. Glycation is believed to be the etiology of various age-related diseases such as diabetes mellitus and Alz-heimer’s disease (AD). Activation of microglia and resident macrophages in the brain by glycated proteins with subsequent oxidative stress and cytokine release may be an important factor in the progression of AD. It is also suggested that interaction between an advanced glycation end product (AGE) and its receptor (RAGE) results in glial activation as well as cy-tokine release and reactive oxygen species release. The use of antioxidants, receptor mediated compounds and reactive oxygen species scavenging enzyme produce an opportunity to in-tervene with AGE-RAGE signaling pathway, and thereby to slow down the progression of aging-related diseases.